Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
236,833,431
-
Total 13F shares
-
26,642,017
-
Share change
-
+1,110,429
-
Total reported value
-
$165,442,000
-
Price per share
-
$6.21
-
Number of holders
-
54
-
Value change
-
+$8,795,325
-
Number of buys
-
28
-
Number of sells
-
16
Institutional Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2018
As of 30 Sep 2018,
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,642,017 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Consonance Capital Management LP, Broadfin Capital, LLC, Aisling Capital LLC, Biomark Capital Management Co. LLC, Vanguard Group Inc, BlackRock Inc., 683 Capital Management, LLC, PURA VIDA INVESTMENTS, LLC, and MORGENS WATERFALL VINTIADIS & CO INC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.